journal article·2022-06Open access

Pathological examination of blended and co-electrospinning hybrid polycaprolactone/polyurethane nanofibers for soft tissue engineering applications

Gholamhosein Kazemzadeh, Nafiseh Jirofti, Davod Mohebbi-Kalhori, Farkhonde Sarhaddi, Reza Taheri

Journal of Industrial Textiles· Volume 51· Issue 4_suppl

Abstract

The main objective of soft tissue engineering (STE) is to improve the quality of life by replacing damaged tissues with synthetic scaffolds. Collagen is the key structural protein of the native extracellular matrix with nano-scale diameter. Accordingly, this study focused on the fabrication of the blended and co-electrospinning hybrid synthetic polycaprolactone/polyurethane (PCL/PU) nanofibers scaffolds and investigates their in-vivo biocompatibility for the development of their clinical applications in STE. The body reactions were evaluated by examination of the edema, foreign body granulomatous reaction, granulation tissue formation, inflammation, calcification, fibroblastic change, and necrosis as the most important healing effects in pathology examination. The blended and co-electrospinning PCL/PU structures were successfully carried out in the nano-scale range without any beads. According to the histopathological examination of PCL, the scant, mild and mild to moderate, and acute and chronic have been reported for edema, foreign body granulomatous reaction, and inflammation, respectively. Also, severe (for edema), moderate (for foreign body granulomatous reaction), and mild to moderate chronic (for inflammation) were observed for PU. In blended PCL/PU nanofibers, decreasing of the edema and foreign body granulomatous reaction and increasing of the granulation tissue formation and inflammation were observed with the increasing composite ratio of PCL from 25 to 75%. Also in the co-electrospinning hybrid PCL/PU nanofibers, increasing edema, granulation tissue formation, and inflammation were observed by increasing the composite ratio of PU from 25 to 75%. Present study suggested that blended hybrid PCL75/PU25 nanofibers are a promising candidate as synthetic nanofibers scaffolds for STE applications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Reconstructive Surgery and Microvascular Techniques · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Chemical and Biomedical Engineering, Chemical Engineering Department, Faculty of Engineering, University of Sistan and Baluchestan, Zahedan, Iran

Department of Pathology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Funding

National Institute for Medical Research Development

References (48)

Show source-provided references
1. 10.1016/B978-0-08-102850-6.00018-810.1016/B978-0-08-102850-6.00018-8 ↗
2. 10.1016/S0962-8924(02)00007-710.1016/S0962-8924(02)00007-7 ↗
3. 10.1039/C8CS00161H10.1039/C8CS00161H ↗
4. Jirofti N · 7 · 3886
5. 10.1016/j.addr.2007.04.02210.1016/j.addr.2007.04.022 ↗
6. 10.3390/membranes801001510.3390/membranes8010015 ↗
7. 10.1098/rsif.2015.025410.1098/rsif.2015.0254 ↗
8. 10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.0.CO;2-C10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.0.CO;2-C ↗
9. 10.2147/IJN.S19269910.2147/IJN.S192699 ↗
10. 10.1155/2019/460509210.1155/2019/4605092 ↗
11. 10.1016/j.msec.2020.11069210.1016/j.msec.2020.110692 ↗
12. 10.1098/rsos.18053610.1098/rsos.180536 ↗
13. 10.1088/1748-605X/aad4b510.1088/1748-605X/aad4b5 ↗
14. 10.1186/s13036-019-0199-710.1186/s13036-019-0199-7 ↗
15. 10.1089/ten.tec.2012.074110.1089/ten.tec.2012.0741 ↗
16. 10.1016/j.msec.2018.10.01610.1016/j.msec.2018.10.016 ↗
17. 10.1016/j.stem.2018.02.00910.1016/j.stem.2018.02.009 ↗
18. 10.15171/ijbsm.2017.1210.15171/ijbsm.2017.12 ↗
19. 10.1016/j.ijbiomac.2021.01.20910.1016/j.ijbiomac.2021.01.209 ↗
20. 10.1126/scitranslmed.300933710.1126/scitranslmed.3009337 ↗
21. 10.1146/annurev-pathol-020712-16393010.1146/annurev-pathol-020712-163930 ↗
22. 10.1038/nm.280710.1038/nm.2807 ↗
23. 10.1002/path.410410.1002/path.4104 ↗
24. 10.1002/jbm.a.3488910.1002/jbm.a.34889 ↗
25. 10.1016/j.biomaterials.2008.05.02410.1016/j.biomaterials.2008.05.024 ↗
26. 10.1128/CMR.14.2.244-269.200110.1128/CMR.14.2.244-269.2001 ↗
27. 10.1016/j.colsurfb.2018.01.05410.1016/j.colsurfb.2018.01.054 ↗
28. 10.3402/ljm.v9.2543110.3402/ljm.v9.25431 ↗
29. 10.1177/152808372096326810.1177/1528083720963268 ↗
30. 10.1088/1748-605X/ab874310.1088/1748-605X/ab8743 ↗
31. 10.1007/s13239-017-0338-610.1007/s13239-017-0338-6 ↗
32. 10.2147/nano.2006.1.1.1510.2147/nano.2006.1.1.15 ↗
33. 10.3390/fib707006610.3390/fib7070066 ↗
34. 10.1063/1.292443910.1063/1.2924439 ↗
35. 10.1039/C4TA06845A10.1039/C4TA06845A ↗
36. 10.1186/s13036-018-0122-710.1186/s13036-018-0122-7 ↗
37. 10.1111/cid.1227410.1111/cid.12274 ↗
38. 10.1016/j.smim.2007.11.00410.1016/j.smim.2007.11.004 ↗
39. Desmouliere A · Am J Pathol · 1995 · 146 · 56
40. 10.1006/jsre.2001.608910.1006/jsre.2001.6089 ↗
41. 10.1039/D1TB00067E10.1039/D1TB00067E ↗
42. 10.1002/adfm.20060115810.1002/adfm.200601158 ↗
43. 10.2217/nnm-2017-001710.2217/nnm-2017-0017 ↗
44. 10.1186/s41038-017-0069-910.1186/s41038-017-0069-9 ↗
45. 10.1002/adhm.20200081810.1002/adhm.202000818 ↗
46. 10.1002/wnan.132010.1002/wnan.1320 ↗
47. 10.1681/ASN.200410089510.1681/ASN.2004100895 ↗
48. 10.1016/S0014-4827(02)00027-710.1016/S0014-4827(02)00027-7 ↗